Daily overview

Selection from Decision-Making Practice – 17/2026

Pharmeca a.s. 02. 09. 2026

The first assessment reports have been issued in proceedings concerning immunological medicinal products conducted under the new rules introduced by the amendment to the Public Health Insurance Act.

As part of these proceedings, the importance of vaccination was assessed from several key perspectives:

  • Societal and social benefits – the assessment considered not only the impact...
    Are you interested in reading regular commentaries on decisions by Pharmeca a.s.? Feel free to contact us.

    At Pharmeca, we help you navigate the complex landscape of pharmaceutical and medical device information. We also offer flexible services that can be tailored to your needs at any time.

    Our market position and experience allow us to support you whenever you need expert guidance.

    Our knowledge, your opportunity.
Back to news listing